Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Minesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology
|
October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial
Joshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Minesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology
|
October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial
Joshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Page
of 17